Praxis Precision Medicines, Inc.
ION CHANNEL MODULATORS
Last updated:
Abstract:
Provided, in part, are compounds of Formula I: ##STR00001## pharmaceutically acceptable salts thereof, and pharmaceutical compositions thereof, which are useful in the treatment of conditions associated with the activity of sodium channels. Methods of treating a disease or condition relating to aberrant function of a sodium ion channel including neurological disorders (e.g., Dravet syndrome, epilepsy), pain, and neuromuscular disorders are also provided herein.
Status:
Application
Type:
Utility
Filling date:
4 Mar 2022
Issue date:
30 Jun 2022